Status:

WITHDRAWN

Promoting Equity for Cancer Screening and Follow-up

Lead Sponsor:

Mayo Clinic

Conditions:

Colorectal (Colon or Rectal) Cancer

Eligibility:

All Genders

50-75 years

Phase:

NA

Brief Summary

This is a randomized trial to assess the efficacy of reminder mechanisms on colorectal cancer (CRC) screening uptake among a cohort of patients who were previously mailed a multitarget stool DNA (mt-s...

Detailed Description

Colorectal cancer (CRC) is the third leading cause of cancer-related death in the United States, and screening has been shown to reduce mortality from CRC. Screening is underutilized in the United Sta...

Eligibility Criteria

Inclusion

  • Adults, between 50 to 75 years old.
  • Due for colorectal cancer screening based on not having a record of a colonoscopy within 10 years, sigmoidoscopy, or CT colonography within 5 years, mt-sDNA within 3 years, or FIT within 1 year.
  • Asymptomatic for colorectal cancer such as rectal bleeding or reported abdominal mass.

Exclusion

  • For the intervention study, patients will be restricted to those aged 50 to 75 years and are due for colorectal cancer screening.
  • We will exclude any patient who has:
  • Had prior colonoscopy within 10 years, sigmoidoscopy within 5 years, mt-sDNA within 3 years, CT colonography within 5 years, and FOBT/FIT within twelve months of inclusion into the study;
  • A diagnosis of CRC or other GI cancer;
  • History of confirmed Inflammatory Bowel Disease (Crohn's disease, ulcerative colitis) or other colitis;
  • Had a colectomy, partial or total;
  • A diagnosis of Lynch Syndrome;
  • A diagnosis of Familial Adenomatous Polyposis (FAP);
  • Iron deficiency anemia;
  • Lower GI bleeding;
  • A metastatic (Stage IV) blood or solid tumor cancer;
  • End stage renal disease;
  • A first degree relative with CRC prior to age 50 or 2+ first degree relatives diagnosed at any age.

Key Trial Info

Start Date :

September 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2023

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04831827

Start Date

September 1 2021

End Date

May 1 2023

Last Update

October 27 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Mayo Clinic in Rochester

Rochester, Minnesota, United States, 55905